ALVO•benzinga•February 21, 2025 at 11:04 AM

Teva Pharmaceuticals And Alvotech Announce U.S. Availability of SELARSDI (Ustekinumab-aekn) Injection, A Biosimilar To Stelara For Treatment Of Psoriatic Arthritis, Plaque Psoriasis, Crohn's Disease, Ulcerative Colitis, Pediatric Plaque Psoriasis And Pedi

No summary available.

Read the full article from the original source for complete details and context.

Article published on February 21, 2025 by benzinga